Bolz Matthias

Kallab Martin, Vieboeck Isabella, Panahi Parsa, Mansouri Kaweh, Bolz Matthias, Huang Alex S et al.

Excimer laser trabeculostomy significantly improved aqueous humor outflow, even beyond the treatment site, suggesting potential for enhanced glaucoma treatment.

Schuhmayer Anna C, Karl Nina A M, Pomberger Leon, Eidherr Markus, Khalil Haidar, Kallab Martin et al.

This study found Faricimab caused a faster reduction in retinal blood flow than Aflibercept, while both equally reduced choroidal flow. This suggests differing Tie2 receptor distribution, impacting anti-VEGF treatment effects.

Kallab Martin, Huang Alex S, Bolz Matthias, Strohmaier Clemens A

This review found AS-OCT/AS-OCTA shows promise for assessing glaucoma bleb function after surgery, but inconsistent study methods currently limit its routine clinical application.

Hinterberger Sarah, Schneider Sophie, Kallab Martin, Murauer Olivia, Reisinger Anna-Sophie, Bolz Matthias et al.

This real-world study found the Preserflo MicroShunt achieved 60.5% overall success at two years, significantly reducing IOP and medication, offering a viable surgical option for diverse glaucoma patients.

Schneider Sophie, Kallab Martin, Murauer Olivia, Reisinger Anna-Sophie, Strohmaier Susanne, Huang Alex S et al.

Early bleb vessel density measured by AS-OCTA after Preserflo Microshunt surgery predicts future surgical revisions, offering an objective biomarker for bleb failure risk.

Calzetti Giacomo, Mursch-Edlmayr Anna Sophie, Bata Ahmed M, Ungaro Nicola, Mora Paolo, Chua Jacqueline et al.

This study found optic nerve head perfusion (LSFG) correlates better with visual field loss in glaucoma than OCT, particularly in advanced stages, suggesting it's a promising monitoring tool.

Mariacher Siegfried, Laubichler Peter, Mariacher Martina, Wendelstein Jascha, Fischinger Isaak, Bolz Matthias

This study found femtosecond laser full-contact docking significantly elevates IOP more than fluid-filled docking. Lowering baseline IOP reduces this rise, clinically relevant for patient safety during surgery.

Mariacher Siegfried, Laubichler Peter, Wendelstein Jascha, Mariacher Martina, Bolz Matthias

Studying porcine eyes, preoperative IOP strongly predicted intraoperative IOP rise during femtosecond laser cataract surgery vacuum application, more so than vacuum level, suggesting careful preoperative assessment for high-risk patients.

Mursch-Edlmayr Anna S, Luft Nikolaus, Podkowinski Dominika, Ring Michael, Schmetterer Leopold, Bolz Matthias

This study found the water drinking test didn't significantly alter optic nerve head blood flow or ocular perfusion in NTG patients or controls, limiting its utility for assessing autoregulation.

Mursch-Edlmayr Anna Sophie, Luft Nikolaus, Podkowinski Dominika, Ring Michael, Schmetterer Leopold, Bolz Matthias

Aflibercept injections for nAMD significantly reduced optic nerve head and choroidal blood flow in treated eyes, a finding with potential long-term implications for ocular health.

Mursch-Edlmayr Anna Sophie, Luft Nikolaus, Podkowinski Dominika, Ring Michael, Schmetterer Leopold, Bolz Matthias

Aflibercept injection for AMD caused a short-term, IOP-independent reduction in optic nerve head perfusion in the treated eye, but choroidal flow remained stable. This suggests a direct pharmacological effect.

Mitsch Christoph, Pemp Berthold, Kriechbaum Katharina, Bolz Matthias, Scholda Christoph, Schmidt-Erfurth Ursula

PRP for PDR causes early retinal nerve fiber layer swelling and late photoreceptor/RPE thinning, indicating diffuse inflammation and morphometric changes detectable by OCT.

Funk Marion, Schmidinger Gerald, Maar Noemi, Bolz Matthias, Benesch Thomas, Zlabinger Gerhard J et al.

This study found DME eyes have elevated MCP-1 and IL-8. Bevacizumab significantly reduced VEGF, but this reduction didn't correlate with clinical improvement, suggesting other inflammatory pathways are key.